NL7409770A - Werkwijze voor de bereiding van niet-immunogene polypeptiden, werkwijze voor de bereiding van geneesmiddelen, die-immunogene polypeptiden be- vatten en de aldus gevormde geneesmiddelen. - Google Patents
Werkwijze voor de bereiding van niet-immunogene polypeptiden, werkwijze voor de bereiding van geneesmiddelen, die-immunogene polypeptiden be- vatten en de aldus gevormde geneesmiddelen.Info
- Publication number
- NL7409770A NL7409770A NL7409770A NL7409770A NL7409770A NL 7409770 A NL7409770 A NL 7409770A NL 7409770 A NL7409770 A NL 7409770A NL 7409770 A NL7409770 A NL 7409770A NL 7409770 A NL7409770 A NL 7409770A
- Authority
- NL
- Netherlands
- Prior art keywords
- preparation
- immunogenic polypeptides
- medicinal properties
- biocatalyst
- polyalkyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38119173A | 1973-07-20 | 1973-07-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL7409770A true NL7409770A (nl) | 1975-01-22 |
Family
ID=23504063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL7409770A NL7409770A (nl) | 1973-07-20 | 1974-07-19 | Werkwijze voor de bereiding van niet-immunogene polypeptiden, werkwijze voor de bereiding van geneesmiddelen, die-immunogene polypeptiden be- vatten en de aldus gevormde geneesmiddelen. |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS5623587B2 (nl) |
CA (1) | CA1033673A (nl) |
CH (1) | CH616942A5 (nl) |
DE (1) | DE2433883C2 (nl) |
FR (1) | FR2313939A1 (nl) |
GB (1) | GB1469472A (nl) |
IL (1) | IL45291A0 (nl) |
NL (1) | NL7409770A (nl) |
SE (1) | SE441753B (nl) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0027161A1 (de) * | 1979-07-27 | 1981-04-22 | Hoechst Aktiengesellschaft | Insulinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58145691U (ja) * | 1982-03-29 | 1983-09-30 | 株式会社タイト− | テ−ブル型ビデオゲ−ム機 |
JPS5976288U (ja) * | 1982-11-15 | 1984-05-23 | 大平技研工業株式会社 | テ−ブル型テレビゲ−ム機 |
WO1985003934A1 (en) * | 1984-03-06 | 1985-09-12 | Takeda Chemical Industries, Ltd. | Chemically modified protein and process for its preparation |
JPS59204130A (ja) * | 1983-04-30 | 1984-11-19 | Nippon Chemiphar Co Ltd | 新規プラスミノ−ゲンアクチベ−タ誘導体を含有してなる経口投与薬剤 |
DE3334407A1 (de) * | 1983-09-23 | 1985-04-04 | Hoechst Ag, 6230 Frankfurt | In position b 30 modifizierte insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus |
JPH0327674Y2 (nl) * | 1984-10-02 | 1991-06-14 | ||
JPS61163687U (nl) * | 1985-03-28 | 1986-10-09 | ||
JPS62207485A (ja) * | 1986-03-07 | 1987-09-11 | 大平技研工業株式会社 | テレビゲ−ム機 |
US5037969A (en) * | 1986-07-03 | 1991-08-06 | Takeda Chemical Industries, Ltd. | Glycosyl derivatives and use thereof |
US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
US5578496A (en) * | 1991-12-19 | 1996-11-26 | Board Of Regents, Baylor College Of Medicine | Detection of autoantibodies associated with the disease myasthenia gravis |
AU3423293A (en) * | 1991-12-19 | 1993-07-19 | Baylor College Of Medicine | Pva or peg conjugates of peptides for epitope-specific immunosuppression |
US5618528A (en) * | 1994-02-28 | 1997-04-08 | Sterling Winthrop Inc. | Biologically compatible linear block copolymers of polyalkylene oxide and peptide units |
US6541629B1 (en) * | 1999-09-10 | 2003-04-01 | The Procter & Gamble Company | Enzyme inhibitors |
US6323311B1 (en) | 1999-09-22 | 2001-11-27 | University Of Utah Research Foundation | Synthesis of insulin derivatives |
DK1578771T3 (da) * | 2001-10-10 | 2013-06-10 | Novo Nordisk As | Remodellering og glycokonjugering af peptider |
PT1436012T (pt) * | 2001-10-18 | 2018-03-27 | Nektar Therapeutics | Conjugados poliméricos de antagonistas de opióides |
BR0308710A (pt) * | 2002-03-26 | 2007-01-09 | Biosynexus Inc | conjugados poliméricos antimicrobianos |
US20040062748A1 (en) * | 2002-09-30 | 2004-04-01 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
WO2004037310A2 (en) * | 2002-10-21 | 2004-05-06 | Allvivo, Inc. | Surface coating comprising bioactive compound |
CA2540138C (en) | 2003-09-24 | 2013-07-30 | Kyowa Hakko Kogyo Co., Ltd. | Recombinant antibody against human insulin-like growth factor |
US7790835B2 (en) | 2003-12-03 | 2010-09-07 | Nektar Therapeutics | Method of preparing maleimide functionalized polymers |
US20090042790A1 (en) * | 2005-06-13 | 2009-02-12 | Nastech Pharmaceutical Company Inc. | Transmucosal delivery of peptide derivatives |
US7301003B2 (en) * | 2005-08-26 | 2007-11-27 | Enzon Pharmaceuticals, Inc. | Method of preparing polymers having terminal amine groups |
US10046058B2 (en) * | 2014-12-02 | 2018-08-14 | Rezolute, Inc. | Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates |
US20170342211A1 (en) * | 2016-05-31 | 2017-11-30 | Robert Bosch Gmbh | Azlactone functionalized substrates for conjugation of biomolecules |
EP4019007A1 (en) * | 2016-06-01 | 2022-06-29 | Servier IP UK Limited | Formulations of polyalkylene oxide-asparaginase and methods of making and using the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE337223B (nl) * | 1967-05-23 | 1971-08-02 | Pharmacia Ab | |
US3619371A (en) * | 1967-07-03 | 1971-11-09 | Nat Res Dev | Production of a polymeric matrix having a biologically active substance bound thereto |
US3674767A (en) * | 1967-07-14 | 1972-07-04 | Nat Res Dev | Novel polymeric materials containing triazinyl groups |
-
1974
- 1974-07-15 DE DE2433883A patent/DE2433883C2/de not_active Expired
- 1974-07-17 IL IL45291A patent/IL45291A0/xx unknown
- 1974-07-18 SE SE7409366A patent/SE441753B/xx not_active IP Right Cessation
- 1974-07-18 GB GB3186174A patent/GB1469472A/en not_active Expired
- 1974-07-19 CH CH997274A patent/CH616942A5/de not_active IP Right Cessation
- 1974-07-19 FR FR7425288A patent/FR2313939A1/fr active Granted
- 1974-07-19 CA CA205,144A patent/CA1033673A/en not_active Expired
- 1974-07-19 NL NL7409770A patent/NL7409770A/nl unknown
- 1974-07-20 JP JP8373374A patent/JPS5623587B2/ja not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0027161A1 (de) * | 1979-07-27 | 1981-04-22 | Hoechst Aktiengesellschaft | Insulinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
Also Published As
Publication number | Publication date |
---|---|
SE7409366L (nl) | 1975-01-21 |
CH616942A5 (en) | 1980-04-30 |
SE441753B (sv) | 1985-11-04 |
FR2313939B1 (nl) | 1979-05-18 |
JPS5623587B2 (nl) | 1981-06-01 |
CA1033673A (en) | 1978-06-27 |
DE2433883C2 (de) | 1986-03-27 |
FR2313939A1 (fr) | 1977-01-07 |
JPS5042087A (nl) | 1975-04-16 |
DE2433883A1 (de) | 1976-02-05 |
GB1469472A (en) | 1977-04-06 |
IL45291A0 (en) | 1974-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL7409770A (nl) | Werkwijze voor de bereiding van niet-immunogene polypeptiden, werkwijze voor de bereiding van geneesmiddelen, die-immunogene polypeptiden be- vatten en de aldus gevormde geneesmiddelen. | |
ATE87946T1 (de) | Polymer, seine herstellung und verwendung. | |
SE7503542L (nl) | ||
AT341215B (de) | Verfahren zur herstellung stabiler, lagerfahiger, nichtwasseriger polymerdispersionen | |
AT343903B (de) | Verfahren zur herstellung wasserloslicher, hochmolekularer polymerisate | |
IE37602L (en) | Cyclocpentane derivatives | |
OA04771A (fr) | Nouveaux 2, 3-dihydrobenzofuranyl-7-N-méthylcarbamates N-sulfénylés, leur procédé de préparation et leur application comme insecticide. | |
BE826875A (fr) | Nouveaux complexes metalliferes utilisables comme stabilisants de matieres organiques et leur preparation | |
NL7411531A (nl) | Koolzuurderivaten van 2-mercapto 4.5-dichloor- thiazolen, alsmede werkwijze voor de bereiding en toepassing ervan als herbiciden. | |
NL7514553A (nl) | Werkwijze voor de bereiding van tandpasta's. | |
NL7611554A (nl) | Werkwijze voor het bereiden van polycarbonaat- polymeren alsmede gevormd voortbrengsel, geheel of ten dele bestaande uit aldus verkregen poly- carbonaatpolymeer. | |
NL7500647A (nl) | Werkwijze voor de bereiding van gesinterde te- trafluorethyleenpolymeerharsen. | |
ES427869A1 (es) | Procedimiento para la preparacion de esteres alcoholicos deacido 5-fenilsulfinil-2-bencimidazol-carbamico. | |
NL181358C (nl) | Werkwijze voor de bereiding van 3,6-dichloorpicolinezuur. | |
RO68748A (ro) | Procedeu pentru prepararea unor derivati de 1-sulfonil-2,5(6)-benzimidizol substituiti | |
ES424820A1 (es) | Procedimiento para la obtencion de masas moldeables de or- gano-polisiloxano, almacenables bajo exclusion de agua. | |
ES457416A1 (es) | Un procedimiento para la preparacion de poli(tetrametilen- eter)glicol. | |
FR2290203B1 (nl) | ||
NL7506105A (nl) | Werkwijze voor de bereiding van (alpha).(alpha).(alpha).(alpha)'.(alpha)'.(alpha)'- -hexakisaryl 1.3- respectievelijk -1.4-dimethyl- benzenen. | |
JPS5377300A (en) | Improved proces for preparation of ring-opening polymer | |
NL7411569A (nl) | Werkwijze ter bereiding van 7 (-(2-aminoethyl- -1-cyclohexanyl en 1,4-cyclohexadienyl)-aceet- amido)-3-heterocyclische thiomethyl-3-cefem-4- -carbonzuren en de zouten daarvan, alsmede far- maceutische preparaten die deze verbindingen als actieve component bevatten. | |
NL7613787A (nl) | Werkwijze voor de bereiding van gestabiliseerde lineaire, grootmoleculige polyesters. | |
JPS51136784A (en) | Method f or preparing a polymer containing a a skelton of stabilizer in the molecule | |
ES394637A1 (es) | Procedimiento para estabilizar material organico posible dedegradacion oxidatica o termica. | |
ES427954A1 (es) | Procedimiento para la preparacion de 2-amino - n - ciclohe-xil-3,5-dibromo - n - metil-bencilamina. |